Seattle, WA, United States of America

Heather Kay Webb Hsu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Heather Kay Webb Hsu: Innovator in Pharmaceutical Research

Introduction

Heather Kay Webb Hsu is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments for liver and metabolic diseases. With a total of 2 patents, her work is paving the way for advancements in medical therapies.

Latest Patents

Heather's latest patents include the development of Dichlorophenol HSD17B13 inhibitors and their uses. These patents describe HSD17B13 inhibitors and pharmaceutical compositions that comprise these inhibitors. The subject compounds and compositions are particularly useful for treating liver disease, metabolic disease, or cardiovascular disease, such as non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), as well as drug-induced liver injury (DILI).

Career Highlights

Heather is currently associated with Inipharm, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her research focuses on creating effective solutions for complex health issues, demonstrating her commitment to improving patient outcomes.

Collaborations

Some of her notable coworkers include Sampath Kumar Anandan and Joshua Odingo. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Heather Kay Webb Hsu is a dedicated inventor whose work in pharmaceutical research is making a significant impact on the treatment of liver and metabolic diseases. Her innovative patents and collaborations reflect her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…